CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.48
-0.27 (-9.82%)
At close: Jun 16, 2025, 3:59 PM
2.48
0.20%
Pre-market: Jun 17, 2025, 04:01 AM EDT
-9.82% (1D)
| Bid | 2.46 |
| Market Cap | 389.92M |
| Revenue (ttm) | 147.56M |
| Net Income (ttm) | 41.6M |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 5.16 |
| Forward PE | -6.73 |
| Analyst | Buy |
| Ask | 2.48 |
| Volume | 2,486,383 |
| Avg. Volume (20D) | 4,723,420 |
| Open | 2.83 |
| Previous Close | 2.75 |
| Day's Range | 2.47 - 2.87 |
| 52-Week Range | 0.40 - 3.10 |
| Beta | 2.12 |
About CTMX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTMX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+4.93%
CytomX Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
+129.43%
CytomX Therapeutics shares are trading higher. The company announced a $100 million offering of 76.9 million shares at $1.30 per share.
